Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...

"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

Corvette ZR1 with the ZTK Performance Package and $25,000 cash by supporting MS Solutions and their work for MS patients.

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

"I tell my right foot to go somewhere, and it wants to go somewhere else. I gotta be very precise about, moving around, especially when I start moving fast on stage." ...

Older people wait an average of just over a month to see a neurologist for specialty care after being referred by their primary care physician or another physician, according to a study published in ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability.

Richard Cohen, the Emmy-winning journalist and author, died on 2024 Christmas Eve at the age of 76 after a two-month fight with pneumonia.

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Tiziana Life Sciences (TLSA) announced that a review article titled “Immune mechanisms and shared immune targets in neurodegenerative diseases” ...